Literature DB >> 9502582

A dye-based lymphocyte proliferation assay that permits multiple immunological analyses: mRNA, cytogenetic, apoptosis, and immunophenotyping studies.

Y Zhi-Jun1, N Sriranganathan, T Vaught, S K Arastu, S A Ahmed.   

Abstract

Alamar Blue in the microenvironment of activated cells, undergoes color change and also becomes fluorescent. By using the Alamar Blue dye, we have reported a non-radioactive colorimetric assay to indirectly determine proliferation of murine lymphocytes. We further show that the pattern of mitogen-induced proliferation assessed fluorometrically was comparable to the 3H-thymidine incorporation assay (3H-Tdr assay). Of practical importance is that the color/fluorescence changes were stable at 4 degrees C in the dark for 3-4 weeks. In immunological studies, it is important to further analyze lymphocytes that have undergone activation and/or proliferation. This is not possible with the standard 3H-Tdr assay, which requires lysis of cells. In contrast, the Alamar Blue-based non-radioactive assay does not require cell lysis. We therefore tested the hypothesis that further analysis of lymphocytes is possible, after assessing the proliferation using Alamar Blue. Following assessment of proliferation in a 72-h culture, the Alamar Blue dye was washed-off and cells were re-utilized to perform additional immunological analysis. Short-term exposure of lymphocytes to Alamar Blue was not detrimental to lymphocytes, as assessed by trypan blue exclusion and the propidium iodide (PI) assays. Exposure of dexamethasone-treated cells to Alamar Blue did not interfere with the performance of apoptosis assays, such as flow cytometric analysis of PI-stained cells and microscopic examination of ethidium bromide/acridine orange-stained cells. In addition, prior exposure of lymphocytes to Alamar Blue did not affect the analysis of chromosomal aberrations or the visualization of cell surface antigens by flow cytometry. Further, the expression of cytokine mRNA in lymphocytes previously exposed to Alamar Blue was similar to unexposed cells. Together, a notable advantage of this assay is that it now enables the investigator to maximize information by following or correlating proliferation with other immunologic events in the same cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9502582     DOI: 10.1016/s0022-1759(97)00171-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  22 in total

1.  Inhibition of Fas-mediated apoptosis by antigen: implications for lymphomagenesis.

Authors:  Elaine J Schattner; Steven M Friedman; Paolo Casali
Journal:  Autoimmunity       Date:  2002-07       Impact factor: 2.815

2.  In vitro comparative assessment of different viability assays in Acanthamoeba castellanii and Acanthamoeba polyphaga trophozoites.

Authors:  I Heredero-Bermejo; J L Copa-Patiño; J Soliveri; R Gómez; F J de la Mata; J Pérez-Serrano
Journal:  Parasitol Res       Date:  2013-09-12       Impact factor: 2.289

3.  A High-throughput End-point Assay for Viable Mammalian Cell Estimation.

Authors:  Xianghui Gong; Qiangyi Fang; Xuesen Li; Xiangzong Han; Yuyin Wu; Shengli Yang; Bing Q Shen
Journal:  Cytotechnology       Date:  2005-09       Impact factor: 2.058

4.  Investigating the immunologic effects of CoCr nanoparticles.

Authors:  Bamikole Ogunwale; Andreas Schmidt-Ott; R M Dominic Meek; James M Brewer
Journal:  Clin Orthop Relat Res       Date:  2009-06-30       Impact factor: 4.176

5.  Natural killer cells support the induction of protective immunity during dendritic cell-mediated vaccination against Leishmania major.

Authors:  Katharina A Remer; Bianca Roeger; Christine Hambrecht; Heidrun Moll
Journal:  Immunology       Date:  2010-12       Impact factor: 7.397

6.  Antimalarial activity of natural and synthetic prodiginines.

Authors:  Kancharla Papireddy; Martin Smilkstein; Jane Xu Kelly; Shaimaa M Salem; Mamoun Alhamadsheh; Stuart W Haynes; Gregory L Challis; Kevin A Reynolds
Journal:  J Med Chem       Date:  2011-07-08       Impact factor: 7.446

7.  Noninvasive real-time monitoring by alamarBlue(®) during in vitro culture of three-dimensional tissue-engineered bone constructs.

Authors:  Xiaohua Zhou; Inge Holsbeeks; Saartje Impens; Maarten Sonnaert; Veerle Bloemen; Frank Luyten; Jan Schrooten
Journal:  Tissue Eng Part C Methods       Date:  2013-02-25       Impact factor: 3.056

8.  Blockade of the 4-1BB (CD137)/4-1BBL and/or CD28/CD80/CD86 costimulatory pathways promotes corneal allograft survival in mice.

Authors:  Tatsuhiko Asai; Beom K Choi; Patrick M Kwon; Won Y Kim; Jung D Kim; Dass S Vinay; Bryan M Gebhardt; Byoung S Kwon
Journal:  Immunology       Date:  2007-03-22       Impact factor: 7.397

9.  T cell hybridomas to study MHC-II restricted B-cell receptor-mediated antigen presentation by human B cells.

Authors:  Matthew B Bartley; David H Canaday
Journal:  J Immunol Methods       Date:  2011-05-19       Impact factor: 2.303

10.  The purinergic P2X7 receptor is not required for control of pulmonary Mycobacterium tuberculosis infection.

Authors:  Amy J Myers; Brandon Eilertson; Scott A Fulton; Joanne L Flynn; David H Canaday
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.